{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T15:16:02Z","timestamp":1781968562337,"version":"3.54.5"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>Patients with mycosis fungoides experience considerable morbidity and mortality from secondary bacterial and viral infections. <jats:italic toggle=\"yes\">Staphylococcus aureus<\/jats:italic>, \u03b2-hemolytic streptococci, herpes simplex virus, and herpes zoster virus remain the most common infectious pathogens in this group of patients. With depressed cellular immunity and diminished skin barrier as the main precipitating risk factors, immunocompromised patients can often present with an atypical presentation of a common dermatologic condition. The case herein discusses a clinically atypical nonvesicular Kaposi varicelliform eruption secondary to a varicella-zoster virus in a patient with S\u00e9zary syndrome. Concurrent polypharmacy in these patients is also a risk factor for development of drug hypersensitivity reactions. However, given their immunocompromised status, first and foremost, a careful inspection should be made of every atypical skin eruption in search of an infectious etiology, and afterward, an appropriate treatment should be promptly initiated.<\/jats:p>","DOI":"10.1097\/dad.0000000000001264","type":"journal-article","created":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T19:26:45Z","timestamp":1537990005000},"page":"920-923","source":"Crossref","is-referenced-by-count":5,"title":["Atypical Varicella-Zoster Kaposi Varicelliform Eruption in S\u00e9zary Syndrome"],"prefix":"10.1097","volume":"40","author":[{"given":"Silvija P.","family":"Gottesman","sequence":"first","affiliation":[{"name":"Zucker School of Medicine at Hofstra\/Northwell, Department of Dermatology, Lake Success, NY;"},{"name":"Ackerman Academy of Dermatopathology, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason R.","family":"Rosen","sequence":"additional","affiliation":[{"name":"Ackerman Academy of Dermatopathology, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay D.","family":"Geller","sequence":"additional","affiliation":[{"name":"Dermatology and Cosmetic Medicine Specialists, Chester, NJ; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin B.","family":"Freeman","sequence":"additional","affiliation":[{"name":"Summit Medical Group, Morristown, NJ."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230908","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4103\/0019-5154.96197","article-title":"Psoriasis herpeticum due to varicella zoster virus: a Kaposi's varicelliform eruption in erythrodermic psoriasis","volume":"57","author":"Garg","year":"2012","journal-title":"Indian J Dermatol."},{"key":"R2-20230908","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1001\/jama.1992.03480100060031","article-title":"Infections complicating mycosis fungoides and S\u00e9zary syndrome","volume":"267","author":"Axelrod","year":"1992","journal-title":"JAMA."},{"key":"R3-20230908","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood."},{"key":"R4-20230908","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2340\/00015555-1523","article-title":"Serum-soluble herpes virus entry mediator levels reflect disease severity and Th2 environment in cutaneous T-cell lymphoma","volume":"93","author":"Miyagaki","year":"2013","journal-title":"Acta Derm Venereol."},{"key":"R5-20230908","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5070\/D34J11Z5Z7","article-title":"Fatal outcome due to bacterial superinfection of eczema herpeticum in a patient with mycosis fungoides","volume":"14","author":"Mallo-garc\u00eda","year":"2008","journal-title":"Dermatol Online J."},{"key":"R6-20230908","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jaad.2005.01.140","article-title":"\u201cPsoriasis herpeticum: three cases of Kaposi's varicelliform eruption in psoriasis.\u201d","volume":"53","author":"Santmyire-Rosenberger","year":"200","journal-title":"J Am Acad Dermatol."},{"key":"R7-20230908","first-page":"237","article-title":"Herpes simplex: auto inoculation versus dissemination","volume":"13","author":"Marcus","year":"2005","journal-title":"Acta Dermatovenerol Croat."},{"key":"R8-20230908","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000018339","article-title":"\u201cDetection of herpes simplex virus DNA in non-herpetic areas of patients with eczema herpeticum.\u201d","volume":"200","author":"Amatsu","year":"2000","journal-title":"Dermatology."},{"key":"R9-20230908","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1172\/JCI24826","article-title":"Immunopathogenesis and therapy of cutaneous T cell lymphoma","volume":"115","author":"Kim","year":"2005","journal-title":"J Clin Invest."},{"key":"R10-20230908","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1046\/j.1365-2230.1997.1920609.x","article-title":"Kaposi's varicelliform eruption in a patient with mycosis fungoides","volume":"22","author":"Hayashi","year":"1997","journal-title":"Clin Exp Dermatol."},{"key":"R11-20230908","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1177\/014107680309601009","article-title":"Disseminated herpes simplex after total skin electron beam radiotherapy for mycosis fungoides","volume":"96","author":"Smith","year":"2003","journal-title":"J R Soc Med."},{"key":"R12-20230908","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1001\/archderm.1978.01640190055019","article-title":"Kaposi's varicelliform eruption in mycosis fungoides","volume":"114","author":"Segal","year":"1978","journal-title":"Arch Dermatol."},{"key":"R13-20230908","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/archderm.1980.01640280044015","article-title":"Herpes zoster-varicella in cutaneous T-cell lymphomas","volume":"116","author":"Vonderheid","year":"1980","journal-title":"Arch Dermatol."},{"key":"R14-20230908","doi-asserted-by":"crossref","first-page":"399","DOI":"10.4103\/2229-5178.169714","article-title":"Kaposi's varicelliform eruption: a case series","volume":"6","author":"Ferrari","year":"2015","journal-title":"Indian Dermatol Online J."},{"key":"R15-20230908","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1067\/S0190-9622(03)00896-X","article-title":"Predisposing factors and clinical features of eczema herpeticum: a retrospective analysis of 100 cases","volume":"49","author":"Wollenberg","year":"2003","journal-title":"J Am Acad Dermatol."},{"key":"R16-20230908","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.3390\/toxins5081402","article-title":"Bacterial toxins fuel disease progression in cutaneous T-cell lymphoma","volume":"5","author":"Willerslev-olsen","year":"2013","journal-title":"Toxins (Basel)."},{"key":"R17-20230908","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2340\/00015555-1886","article-title":"Vorinostat for refractory or relapsing epidermotropic T-cell lymphoma: a retrospective cohort study of 15 patients","volume":"95","author":"Kogge","year":"2015","journal-title":"Acta Derm Venereol."},{"key":"R18-20230908","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3816\/CLM.2009.n.082","article-title":"Evaluation of the long-term tolerability and clinical benefit of vorinostat in patients with advanced cutaneous T-cell lymphoma","volume":"9","author":"Duvic","year":"2009","journal-title":"Clin Lymphoma Myeloma."},{"key":"R19-20230908","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/j.0022-202X.2005.23925.x","article-title":"Selective induction of apoptosis by histone deacetylase inhibitor SAHA in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action","volume":"125","author":"Zhang","year":"2005","journal-title":"J Invest Dermatol."},{"key":"R20-20230908","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/35106079","article-title":"Histone deacetylases and cancer: causes and therapies","volume":"1","author":"Marks","year":"2001","journal-title":"Nat Rev Cancer."}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000372-201812000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T04:11:15Z","timestamp":1694146275000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000372-201812000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":20,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000001264","relation":{},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]}}}